AP
AMGN icon

AHL Partners’s Amgen AMGN Stock Holding History

AHL Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$6.35M Sell
36,510
-8,710
-19% -$1.54M 0.1% 397
2017
Q3 		$8.43M Buy
45,220
+12,502
+38% +$2.22M 0.15% 226
2017
Q2 		$5.63M Buy
32,718
+11,743
+56% +$1.91M 0.12% 306
2017
Q1 		$3.44M Buy
20,975
+4,619
+28% +$767K 0.08% 464
2016
Q4 		$2.39M Buy
16,356
+7,233
+79% +$1.09M 0.07% 455
2016
Q3 		$1.52M Buy
9,123
+2,790
+44% +$472K 0.06% 461
2016
Q2 		$964K Buy
6,333
+1,883
+42% +$293K 0.05% 451
2016
Q1 		$667K Sell
4,450
-13,383
-75% -$1.99M 0.04% 495
2015
Q4 		$2.9M Buy
17,833
+13,657
+327% +$2.15M 0.22% 157
2015
Q3 		$578K Sell
4,176
-29,938
-88% -$4.72M 0.09% 319
2015
Q2 		$5.24M Sell
34,114
-278
-0.8% -$44.5K 0.21% 157
2015
Q1 		$5.5M Buy
34,392
+18,119
+111% +$2.85M 0.22% 136
2014
Q4 		$2.59M Buy
16,273
+14,500
+818% +$2.26M 0.13% 326
2014
Q3 		$249K Buy
+1,773
New +$231K 0.02% 642

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AHL Partners's AMGN Position: Q4 2017 in Review

AHL Partners reduced its Amgen (AMGN) stake by 19% in Q4 2017, selling an estimated $1.54M and leaving 36,510 shares worth $6.35M. The position accounts for 0.1% of the portfolio, ranked #397.

AHL Partners first reported a position in AMGN in Q3 2014 and has held it in 14 quarters since. The position peaked at $8.43M in Q3 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • AHL Partners held 36,510 shares of Amgen worth $6.35M as of Q4 2017.
  • AHL Partners sold 8,710 Amgen shares in Q4 2017, an estimated $1.54M.
  • Amgen made up 0.1% of AHL Partners's portfolio in Q4 2017, its #397 holding.
  • AHL Partners first reported a position in Amgen in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Amgen position peaked at $8.43M in Q3 2017.
  • 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.